Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen forHelicobacter pylorieradication: how should rifabutin be managed in rescue regimens?-Reference-Cited by-同舟云学术

Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen forHelicobacter pylorieradication: how should rifabutin be managed in rescue regimens?

Published:2015-12-15 Issue:3 Volume:4 Page:474-475
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:United European Gastroenterology Journal

Author:

Losurdo Giuseppe¹,Iannone Andrea¹,Giorgio Floriana¹,Principi Mariabeatrice¹,Di Leo Alfredo¹,Ierardi Enzo¹

Affiliation:

1. Gastroenterology Section, Department of Emergency and Organ Transplantation, University of Bari, Italy

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

http://journals.sagepub.com/doi/pdf/10.1177/2050640615623697

Reference11 articles.

1. How antibiotic resistances could changeHelicobacter pyloritreatment: A matter of geography?

2. Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

3. Culture-guided treatment approach forHelicobacter pyloriinfection: Review of the literature

4. Review article: rifabutin in the treatment of refractory Helicobacter pylori infection

5. Outcomes From Treating Tuberculosis With Rifampicin or Rifabutin in HIV-Infected Persons Also Receiving Antiretroviral Therapy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, pharmacokinetics, and efficacy of rifasutenizol, a novel dual-targeted antibacterial agent in healthy participants and patients in China with Helicobacter pylori infection: four randomised clinical trials;The Lancet Infectious Diseases;2024-06

2. Rifabutin as salvage therapy for Helicobacter pylori eradication: Cornerstones and novelties;World Journal of Gastroenterology;2022-12-07

3. Efflux pumps potential drug targets to circumvent drug Resistance – Multi drug efflux pumps of Helicobacter pylori;Materials Today: Proceedings;2021

4. Rifamycin use for treatment of Helicobacter pylori infection: a review of recent data;Future Microbiology;2020-08

5. Current Status of the Third-LineHelicobacter pyloriEradication;Gastroenterology Research and Practice;2018-05-02